CTSO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cytosorbents Corp (CTSO) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock exhibits weak technical indicators, no significant trading trends, and lacks positive catalysts. Additionally, its financial performance shows declining profitability metrics despite revenue growth. Given the absence of Intellectia Proprietary Trading Signals and no recent news or influential trading activity, it is better to hold off on investing in CTSO for now.
The technical indicators suggest a bearish trend. The MACD is below 0 and negatively contracting, the RSI is neutral at 47.953, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot point (0.582) but lacks strong upward momentum.
Revenue increased by 41.56% YoY in Q4 2025, indicating some growth in the top line.
Net income dropped by 30.28% YoY, EPS fell by 35.71% YoY, and gross margin declined by 29.02% YoY. No recent news, no significant hedge fund or insider trading activity, and no recent congress trading data.
In Q4 2025, revenue grew to $9.23M (up 41.56% YoY), but net income dropped to -$5.5M (-30.28% YoY), EPS fell to -0.09 (-35.71% YoY), and gross margin declined to 73.68% (-29.02% YoY).
No recent analyst rating or price target changes available.
